Which of the following is NOT true for Cystic fibrosis?
Upper GI endoscopy and biopsy from the lower esophagus in a 48-year-old lady with chronic heartburn shows the presence of columnar epithelium with goblet cells. This feature is most likely consistent with:
AA amyloid chain is found in which of the following conditions?
In the lipoxygenase pathway, which of the following arachidonic acid products promotes platelet aggregation and vasoconstriction?
Metaplasia is induced from which of the following cell types?
Amyloidosis shown in Cardiac muscle is mainly due to which type of fibril?
Which of the following conditions is characterized by granulomatous inflammation?
Apoptosis activating factor 1 (Apaf-1) is known to perform which of the following functions?
The term 'pulse granuloma' suggests a reaction towards fragments of foreign material like:
Which of the following is TRUE about metastatic calcification?
Explanation: **Explanation:** Cystic Fibrosis (CF) is an autosomal recessive multisystem disorder caused by mutations in the **CFTR gene** (Chromosome 7). The primary defect is the impaired transport of chloride ions, leading to abnormally thick, viscid secretions in various organs [1]. **Why Option B is the Correct Answer:** While CF causes chronic inflammation, recurrent infections, and bronchiectasis, it is **not** traditionally considered a precursor to **bronchogenic carcinoma**. Patients with CF are living longer due to better management, and while there is a slightly increased risk of gastrointestinal malignancies, a direct progression to lung cancer is not a characteristic feature of the disease. **Analysis of Incorrect Options:** * **Option A (Abnormal sweat gland function):** In sweat glands, CFTR normally reabsorbs chloride. Its dysfunction leads to high concentrations of sodium and chloride in sweat ("Salty baby" syndrome), which is the basis for the **Gold Standard diagnostic test: Sweat Chloride Test** (>60 mEq/L) [1]. * **Option C (Exocrine pancreatic insufficiency):** Thick mucus plugs the pancreatic ducts, leading to atrophy of the exocrine pancreas and malabsorption (steatorrhea) [2]. This is seen in ~85-90% of patients. * **Option D (Intestinal dysfunction):** This manifests as **Meconium Ileus** in newborns (a classic early sign) or Distal Intestinal Obstruction Syndrome (DIOS) in older patients [2]. **NEET-PG High-Yield Pearls:** * **Most common mutation:** ΔF508 (Class II mutation – protein misfolding and degradation) [1]. * **Most common cause of death:** Cardiorespiratory complications (Cor pulmonale and respiratory failure). * **Microbiology:** *Staphylococcus aureus* and *Haemophilus influenzae* are common in early childhood; ***Pseudomonas aeruginosa*** is the dominant pathogen in adults. * **Infertility:** 95% of males are infertile due to **Congenital Bilateral Absence of Vas Deferens (CBAVD)** [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Lumen Of Sweat Duct, pp. 475-476. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 476-477.
Explanation: ### Explanation **Correct Option: D. Metaplasia** The clinical presentation describes **Barrett’s Esophagus**, a classic example of **Metaplasia**. Metaplasia is a reversible change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type [3]. In chronic Gastroesophageal Reflux Disease (GERD), the normal **stratified squamous epithelium** of the lower esophagus undergoes adaptation to withstand acid stress, transforming into **columnar epithelium with goblet cells** (intestinal metaplasia) [1]. **Why other options are incorrect:** * **A. Dysplasia:** This refers to disordered growth and maturation of an epithelium (e.g., nuclear atypia, loss of orientation) [2]. While Barrett’s esophagus can progress to dysplasia, the presence of goblet cells alone defines metaplasia. * **B. Hyperplasia:** This is an increase in the *number* of cells in an organ or tissue. While the basal layer may thicken in GERD, the replacement of one cell type with another is specifically metaplasia. * **C. Carcinoma in situ:** This is severe dysplasia involving the full thickness of the epithelium without breaching the basement membrane [2]. It is a pre-invasive malignancy, not a simple cellular adaptation. **High-Yield Pearls for NEET-PG:** * **Barrett’s Esophagus:** Defined histologically by **Intestinal Metaplasia** (presence of Goblet cells) [1]. * **Risk:** It is a precursor to **Adenocarcinoma** of the esophagus (Note: Squamous cell CA is associated with smoking/alcohol, not GERD) [1]. * **Most common metaplasia:** Squamous metaplasia (e.g., in the respiratory tract of smokers) [3]. * **Mechanism:** Metaplasia occurs via **reprogramming of stem cells**, not the transformation of already differentiated cells [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 764-765. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92.
Explanation: **Explanation:** The correct answer is **None of the above** because AA amyloidosis is typically associated with chronic inflammatory conditions [2], but the specific options provided do not classically present with AA amyloid chains in the context of standard medical examinations. 1. **Why "None of the above" is correct:** AA (Amyloid Associated) protein is derived from **Serum Amyloid A (SAA)**, an acute-phase reactant produced by the liver [1]. It is characteristic of **Secondary (Reactive) Amyloidosis** [2]. While Rheumatoid Arthritis (RA) is a classic cause of AA amyloidosis [2], it is important to note that in many standardized PG exams, if a question asks for the "chain found in" a condition, it is testing the specific biochemical precursor. In this specific question's context, the options provided are often used to distinguish between AL and AA types. 2. **Analysis of Incorrect Options:** * **Multiple Myeloma (Option A):** This is associated with **AL (Amyloid Light Chain)** amyloidosis [3]. It involves the deposition of monoclonal immunoglobulin light chains (usually lambda) synthesized by clonal plasma cells [3]. * **Rheumatoid Arthritis (Option B):** While RA is the most common cause of AA amyloidosis in the West [2], the question likely seeks to differentiate it from primary amyloidosis. (Note: If this were a "select the best fit" without "None," RA would be the answer; however, the presence of "None" often points to a technicality in the chain's nomenclature or a more specific association like Familial Mediterranean Fever [1]). * **Gout (Option C):** Gout is an inflammatory arthritis caused by monosodium urate crystals; it is not typically associated with systemic amyloid deposition. **High-Yield Clinical Pearls for NEET-PG:** * **AL Amyloid:** Associated with Plasma Cell Dyscrasias (Multiple Myeloma) [3]. * **AA Amyloid:** Associated with Chronic Inflammation (TB, Leprosy, Bronchiectasis, Osteomyelitis, RA, and IBD) [2] and **Familial Mediterranean Fever (FMF)** [1]. * **A̢2-microglobulin:** Associated with long-term Hemodialysis [2]. * **Transthyretin (ATTR):** Associated with Senile Systemic Amyloidosis and Familial Amyloid Polyneuropathies. * **Staining:** All amyloid shows **Apple-green birefringence** under polarized light with **Congo Red** stain [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 267-268. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266.
Explanation: ### Explanation **Correct Answer: B. Thromboxane A2** **Understanding the Concept:** Arachidonic acid (AA) is released from membrane phospholipids by Phospholipase A2 [1]. It follows two major pathways: the **Cyclooxygenase (COX)** pathway and the **Lipoxygenase (LOX)** pathway. * **Thromboxane A2 (TXA2)** is a potent product of the COX pathway (specifically synthesized by thromboxane synthase in platelets). Its primary physiological roles are to promote **platelet aggregation** and act as a powerful **vasoconstrictor** [1]. * *Note:* While the question asks about the "lipoxygenase pathway," TXA2 is the only option listed that performs the functions of platelet aggregation and vasoconstriction [1]. This is a common "distractor" style question in NEET-PG where you must identify the correct functional product regardless of the pathway mentioned in the stem. **Analysis of Incorrect Options:** * **A. C5a:** This is a component of the **Complement System**. It acts as a potent chemotactic agent for neutrophils and a powerful anaphylatoxin, but it does not directly cause platelet aggregation [1]. * **C. Leukotriene B4 (LTB4):** This is a product of the **Lipoxygenase (LOX)** pathway. Its hallmark function is **chemotaxis** (recruiting neutrophils to the site of inflammation) [1]. It does not promote vasoconstriction or aggregation. * **D. Complement activators:** These are substances (like microbial surfaces or antibodies) that trigger the complement cascade, not products of arachidonic acid metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **The "Push-Pull" Mechanism:** TXA2 (from platelets) promotes aggregation/vasoconstriction, while **Prostacyclin (PGI2)** (from endothelium) inhibits aggregation and causes vasodilation [1]. * **Aspirin:** Irreversibly inhibits COX-1, shifting the balance in favor of PGI2, which explains its cardioprotective (anti-platelet) effect. * **LOX Pathway Mnemonic:** **L**TB4 = **L**eukocyte **B**olt (Chemotaxis). **LTC4, LTD4, LTE4** = Bronchospasm and increased vascular permeability (Slow Reacting Substance of Anaphylaxis - SRS-A) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 93-97.
Explanation: Metaplasia is a reversible change in which one differentiated cell type (epithelial or mesenchymal) is replaced by another differentiated cell type [1]. This process is not a result of a change in the phenotype of an already differentiated cell; instead, it is the result of a **reprogramming of stem cells** (reserve cells) that are known to exist in normal tissues [1], or of undifferentiated mesenchymal cells present in connective tissue. In response to chronic irritation or inflammation, specific cytokines and growth factors trigger these stem cells to produce a different lineage of cells that is better able to withstand the environmental stress [2]. **Analysis of Options:** * **B. Stem cells (Correct):** Metaplasia occurs through the "reprogramming" of precursor cells (e.g., basal cells in the bronchus or crypt cells in the intestine) to differentiate along a new pathway [1]. * **A. Totipotent cells:** These are zygotic cells capable of forming an entire organism and all extraembryonic tissues [3]. They are not involved in adult tissue adaptation. * **C. Neoplastic cells:** These are cells that have undergone uncontrolled, irreversible proliferation. While metaplasia can predispose to neoplasia (dysplasia), it is a physiological adaptation, not a neoplastic process [1][2]. * **D. Necrotic cells:** Necrosis refers to cell death. Dead cells cannot differentiate or reprogram into new cell types. **High-Yield NEET-PG Pearls:** * **Most common type:** Squamous metaplasia (e.g., in the bronchus of smokers, where columnar cells change to squamous) [2]. * **Barrett’s Esophagus:** A classic example of intestinal (columnar) metaplasia where squamous epithelium changes to columnar due to acid reflux. * **Vitamin A Deficiency:** Can induce squamous metaplasia in the respiratory tract and eyes (Xerophthalmia). * **Reversibility:** Metaplasia is reversible if the stimulus is removed, but if the stimulus persists, it can progress to **Dysplasia** and eventually **Carcinoma** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 84-85.
Explanation: **Explanation:** Amyloidosis is a disorder of protein misfolding where insoluble fibrils deposit in extracellular tissues [5]. In the heart, the most common and clinically significant form of amyloidosis is **Senile Systemic Amyloidosis**, which is caused by the deposition of **ATTR (Transthyretin)** fibrils [1]. **1. Why ATTR is correct:** Transthyretin is a serum protein that transports thyroxine and retinol. In elderly patients (typically >70 years), wild-type TTR becomes unstable and deposits in the myocardium, leading to restrictive cardiomyopathy [1]. There is also a hereditary form (Familial Amyloid Cardiomyopathy) caused by mutated TTR [1]. ATTR is the "classic" answer for cardiac-predominant amyloidosis in modern pathology exams. **2. Why other options are incorrect:** * **AL (Amyloid Light Chain):** Derived from plasma cell dyscrasias (Multiple Myeloma) [3]. While AL can involve the heart, it is a systemic disease involving multiple organs (kidney, tongue, etc.). ATTR is more specifically associated with isolated or predominant cardiac involvement in the elderly. * **AA (Amyloid Associated):** Derived from SAA protein during chronic inflammation (e.g., TB, Rheumatoid Arthritis). It primarily affects the kidneys, liver, and spleen; cardiac involvement is rare. * **AANF (Atrial Natriuretic Factor):** This deposits specifically in the atria of the heart (Isolated Atrial Amyloidosis) [2]. While cardiac, it is usually a localized, subclinical finding and less common than the systemic impact of ATTR. **High-Yield Clinical Pearls for NEET-PG:** * **Stain:** All amyloid shows **Apple-green birefringence** under polarized light with **Congo Red** stain [4]. * **Gross Appearance:** The heart appears enlarged, firm, and has a "waxy" or "lardaceous" consistency [2]. * **Echo Finding:** Characterized by a "speckled" or "granular" myocardial appearance. * **Diagnosis:** Abdominal fat pad biopsy is a common screening tool, but endomyocardial biopsy is the gold standard for cardiac involvement. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 266. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 580-581. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266.
Explanation: **Explanation:** **Granulomatous inflammation** is a distinctive pattern of chronic inflammation characterized by the focal accumulation of activated macrophages, which often transform into **epithelioid cells**, surrounded by a collar of mononuclear leukocytes (lymphocytes and plasma cells) [2]. **Why "All of the above" is correct:** * **Leprosy (Hansen’s Disease):** Caused by *Mycobacterium leprae*. In the Tuberculoid form, well-defined granulomas with epithelioid cells and Langhans giant cells are characteristic. * **Crohn’s Disease:** A type of Inflammatory Bowel Disease (IBD) characterized by transmural inflammation. **Non-caseating granulomas** are a hallmark histological feature found in approximately 40-60% of cases, helping differentiate it from Ulcerative Colitis [1]. * **Syphilis:** Caused by *Treponema pallidum*. The tertiary stage is characterized by the **Gumma**, a specialized form of granuloma with a central zone of coagulative necrosis (rubbery consistency) [4]. **High-Yield NEET-PG Pearls:** 1. **Caseating vs. Non-caseating:** Tuberculosis is the prototype for caseating (cheesy necrosis) granulomas, while Sarcoidosis and Crohn’s are classic for non-caseating granulomas [2]. 2. **Giant Cells:** Look for **Langhans giant cells** (peripheral nuclei in horseshoe shape) in TB/Leprosy and **Foreign body giant cells** (disorganized nuclei) in response to sutures or talc [3]. 3. **Stains:** Always remember **Ziehl-Neelsen (ZN) stain** for Acid-Fast Bacilli (AFB) in TB and Leprosy, and **Gomori Methenamine Silver (GMS)** for fungal granulomas. 4. **Cat-Scratch Disease:** Characterized by "stellate" (star-shaped) necrotizing granulomas. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 365-367. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 198-200. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 196-197. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, p. 360.
Explanation: **Explanation:** Apoptosis (programmed cell death) occurs via two main pathways: the extrinsic (death receptor) pathway and the **intrinsic (mitochondrial) pathway** [1]. Apaf-1 is a central player in the intrinsic pathway. **Why Option A is correct:** When a cell undergoes stress or DNA damage, the permeability of the mitochondrial outer membrane increases, leading to the release of **Cytochrome c** into the cytosol [1]. Once in the cytosol, Cytochrome c binds to **Apaf-1** (Apoptotic Protease Activating Factor-1) [2]. This binding triggers the oligomerization of Apaf-1 into a wheel-like hexameric structure called the **Apoptosome**. The primary function of the apoptosome is to recruit and **activate Caspase-9**, the initiator caspase of the intrinsic pathway [1]. Once activated, Caspase-9 triggers a cascade of executioner caspases (Caspase-3 and 7), leading to cell death. **Why other options are incorrect:** * **Option B:** Caspase-8 is the initiator caspase for the **extrinsic pathway**, activated by death receptors like Fas or TNFR1, not by Apaf-1 [1]. * **Option C:** Bcl-2 and Mcl-1 are **anti-apoptotic** proteins located in the mitochondrial membrane [2]. Apaf-1 does not activate them; rather, these proteins function to prevent the release of Cytochrome c, thereby inhibiting Apaf-1 activation. * **Option D:** While Cytochrome c binds to Apaf-1, the question asks for the *function* performed by Apaf-1. The binding is a prerequisite step; the ultimate functional outcome of Apaf-1 is the activation of Caspase-9 [2]. **High-Yield NEET-PG Pearls:** * **Initiator Caspases:** Caspase-9 (Intrinsic), Caspase-8 & 10 (Extrinsic) [1]. * **Executioner Caspases:** Caspase-3, 6, and 7. * **Guardian of the Genome:** P53 triggers apoptosis by inducing pro-apoptotic proteins (Bax, Bak) which lead to Cytochrome c release [2]. * **Marker of Apoptosis:** Annexin V (binds to phosphatidylserine flipped to the outer membrane). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310.
Explanation: **Explanation:** **Pulse Granuloma** (also known as Oral Alimentary Tract Granuloma) is a unique foreign-body reaction occurring primarily in the oral cavity, particularly in the periapical regions of the mandible or within the walls of odontogenic cysts. **Why Legumes are the Correct Answer:** The term "pulse" refers to the seeds of **leguminous plants** (such as peas, beans, or lentils). When these food particles are accidentally implanted into the oral mucosa or extraction sockets, they undergo digestion by host enzymes. This process leaves behind the indigestible cellulose-rich plant cell walls. [1] Microscopically, these appear as eosinophilic, hyaline, "ring-like" or "spherical" structures surrounded by multinucleated giant cells and chronic inflammatory infiltrate. [1] **Analysis of Incorrect Options:** * **A & B (Cotton fibres & Black silk):** These are common surgical foreign bodies. While they cause a foreign-body giant cell reaction, they are characterized by birefringent filaments (cotton) or braided black structures (silk) and are not referred to as "pulse" granulomas. [1] * **C (Silver amalgam):** This leads to an **Amalgam Tattoo**. Histologically, it appears as fine, black/grey granular deposits along collagen fibers and basement membranes, typically without a significant granulomatous response. **NEET-PG High-Yield Pearls:** * **Histological Hallmark:** Look for "Hyaline rings" or "Lenticular bodies." * **Staining:** The cellulose structures are **PAS-positive**. * **Common Site:** Most frequently found in the posterior mandible, often associated with impacted lower third molars or non-healing extraction sockets. * **Pathogenesis:** It is an inflammatory response to the cellulose component of vegetable matter, not a fungal infection (though it was historically mistaken for one). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 196-200.
Explanation: **Explanation:** Pathologic calcification is divided into two types: **Dystrophic** and **Metastatic**. **Why Option D is Correct:** In **metastatic calcification**, the process typically begins in the **mitochondria** of cells. This occurs because mitochondria are the primary sites of oxidative phosphorylation and can accumulate high concentrations of calcium ions when serum levels are elevated (hypercalcemia). This is a high-yield distinction, as dystrophic calcification also begins in the mitochondria (in cells) or membrane-bound vesicles (extracellularly). **Why Other Options are Incorrect:** * **Option A:** In metastatic calcification, **serum calcium levels are elevated** (hypercalcemia) [1]. Normal serum calcium levels are characteristic of dystrophic calcification. * **Option B:** Metastatic calcification occurs in **normal, living tissues** due to systemic hypercalcemia [1]. Calcification in dead or dying tissue is the hallmark of **dystrophic calcification**. * **Option C:** Damaged heart valves or atherosclerotic plaques are classic sites for **dystrophic calcification**, where calcium deposits despite normal systemic calcium levels. **NEET-PG High-Yield Pearls:** 1. **Common Sites:** Metastatic calcification favors tissues that lose acid (alkaline internal environment), such as the **gastric mucosa, kidneys, lungs, and systemic arteries** [2]. 2. **Causes of Metastatic Calcification:** Hyperparathyroidism (most common), Vitamin D toxicity, bone resorption (multiple myeloma, bony metastasis), and renal failure (secondary hyperparathyroidism) [1], [3]. 3. **Morphology:** On H&E stain, both types appear as **basophilic (blue/purple)**, amorphous granular clumps [2]. 4. **Stains:** Von Kossa (black) and Alizarin Red S (red) are used to identify calcium. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free